Decision Question This Instrument Addresses
"Do we understand the governance architecture that controls market access: before we commit commercial resources to Saudi healthcare?"
Each dimension targets a specific failure mode that causes decisions of this type to go wrong. The instrument surfaces the gaps most likely to be consequential: not maturity against an idealised standard.
Governance Architecture Mapping
Can you accurately map who controls what across MOH, HHC, CNHI, CHI, and the Insurance Authority – and which body's approval is the actual gate for your specific product or service category?
Regulatory Positioning
Do you understand your regulatory pathway across SFDA, NDMO, data localisation requirements, and product registration: before initiating market engagement?
Commercial Readiness
Is your pricing model, procurement channel strategy, and reference pricing understanding compatible with how Saudi healthcare actually procures and pays?
Partnership Architecture
Have you mapped the required local partnership structure, understood the liability implications, and confirmed that your intended operating model is legally and commercially viable?
Timeline Realism
Is your commercial plan built on a realistic 12–24 month engagement timeline – or on assumptions that will result in 12–18 months of circular conversations before a single decision is reached?
Typical Audience
International healthcare vendors, med-tech companies, digital health platforms, pharmaceutical and health insurance organisations seeking Saudi market access